A Stage-matched Intervention Based on Transtheoretical Model of Change in Changing the Videogaming Behavior
Launched by UNIVERSITY OF BAGHDAD · Jul 9, 2023
Trial Information
Current as of November 07, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is testing whether a stage-by-stage, tailored program can help prevent or reduce problematic digital gaming among high school boys. It uses a randomized design, meaning participants are placed by chance into either the special stage-matched program or a comparison group. The program is based on the Transtheoretical Model of Change, so the features you get depend on your current “stage” of readiness to change your gaming habits (from not thinking about changing to maintaining healthier habits). The main outcome they will look at is how ready a student feels to avoid problematic gaming, measured about 6 months after starting.
To be eligible, a student must be a high school male aged 15 to 20, without any psychiatric disorder, and willing to participate as a healthy volunteer. About 144 students are expected to join, and the study is taking place at the University of Baghdad in Iraq. If enrolled, you would be randomly assigned to receive the stage-matched intervention or a control condition, with follow-up assessments about 12 weeks apart and a final check around 6 months to see changes in readiness to change gaming behavior. This is a behavioral, non-drug study and is not FDA-regulated.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • High school male students who do not experience any psychiatric-mental disorder.
- Exclusion Criteria:
- • High school male students who experience any psychiatric-mental disorder.
About University Of Baghdad
The University of Baghdad, a leading academic institution in Iraq, is committed to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies. The institution aims to contribute valuable insights into various health conditions, fostering an environment of scientific inquiry and ethical research practices that ultimately enhance patient care and public health in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, Iraq
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported